Skip to content

Addiction: all studies

Page 373 of 857: studies 3,721 to 3,730 of 8,563, newest first. Back to the addiction overview

Research

Pour une histoire de l’usage médical des stupéfiants : état des lieux et perspectives

Histoire, Médecine et Santé 2024 Zoë Dubus

L’historiographie en général et celle produite en France en particulier présente traditionnellement les stupéfiants comme des substances indistinctement dangereuses. Ce cadrage systématique sur les phénomènes d’addictions, de déviance et de risques pour l’usager·ère ou la société, repérable par exemple dans la majorité des thèses d’histoire soutenues sur la question des psychotropes, occulte...

MOLECULES OF CONSCIOUSNESS: THE ROLE OF NEUROTRANSMITTERS IN PSYCHIATRY AND SPIRITUAL EXPERIENCES

ARMENIAN JOURNAL OF MENTAL HEALTH 2024 M.g. Yeghiyan, D.a. Palyan

The human brain is a unique and complex system where neurotransmitters are not merely biological components but may serve as "divine tools" enabling higher states of consciousness. Endogenous DMT (dimethyltryptamine) emerges as a key substance capable of inducing altered states of awareness linked to profound spiritual and mystical experiences. Research suggests that DMT, produced naturally in...

Dissociation and Temporality in Substance Abuse: A Clinical Phenomenological Overview.

Psychopathology 2024 Valerio Ricci, Giuseppe Maina, Giovanni Martinotti 11 citations

The term "dissociation" encompasses a wide array of symptoms and phenomena, all sharing the common characteristic of involving altered states of consciousness where an individual temporarily loses the sense of continuity of their own identity. In the context of addiction pathology, however, the dissociative paradigm remains a topic of ongoing debate. It fluctuates between the description of...

Are Psychedelic Experiences Transformative? Can We Consent to Them?

Perspectives in biology and medicine 2024 Brent M Kious, Andrew Peterson, Amy L. Mcguire 21 citations

Psychedelic substances have great promise for the treatment of many conditions, and they are the subject of intensive research. As with other medical treatments, both research and clinical use of psychedelics depend on our ability to ensure informed consent by patients and research participants. However, some have argued that informed consent for psychedelic use may be impossible, because...

Analysis of Epistemic Experiences in Mystical Prose Texts (With a Focus on Nūr al-ʿUlūm, al-Nūr, and Tamhīdāt)

Treasury of Persian Language and Literature 2024 Zahra Mohammadi, Hanieh Sadri Majd, Zohreh Nooraeinia

Mystical experiences are a form of direct awareness of the presence of God or the transcendent truth, which the mystic attains through methods such as meditation, seclusion, remembrance (dhikr), asceticism, and divine love. These experiences emerge through detachment from worldly dependencies and deep internal focus, leading to a state in which the mystic perceives a sense of unity with the...

DOI: 10.61838/jtpll.67 (opens in new tab) Mysticism Perspective graphical Focus optics Materialism +6

Panini and Psilocybin

Dialogue: A Journal of Mormon Thought 2024 Bridget Verhaaren

“Pretty girls don't buy cocaine,” Greta1 says and laughs as she walks out the front door. My hands and face sting as I stand frozen in the entryway and hear her start the car. I'd asked my twenty-two-year-old daughter where she got the money to feed the addictions she was battling. Over the past three years, she'd chosen a few subpar boyfriends who introduced her to substances, which helped set...

Potential therapeutic use of ayahuasca: A literature review

Acta Amazonica 2024 Salvana Priscylla Manso Costa, Keith Cardoso Carvalho, Isabella Nunes Gomes et al. 4 citations

ABSTRACT Ayahuasca is a psychoactive decoction originally used in indigenous Amazonian culture. It consists of a dense brown liquid that most frequently results from the decoction of two plants native to the Amazon rainforest, Psychotria viridis (Rubiaceae) and Banisteriopsis caapi (Malpighiaceae). The composition of the decoction is variable, as several plant species can be used in its...

Antidepressants enter cells, organelles, and membranes.

Neuropsychopharmacology 2024 Zack Blumenfeld, Kallol Bera, Eero Castrén et al. 10 citations

We begin by summarizing several examples of antidepressants whose therapeutic actions begin when they encounter their targets in the cytoplasm or in the lumen of an organelle. These actions contrast with the prevailing view that most neuropharmacological actions begin when drugs engage their therapeutic targets at extracellular binding sites of plasma membrane targets-ion channels, receptors,...

Introduction to the Special Section on Psychedelics Research and Treatment

Perspectives in biology and medicine 2024 Dominic Sisti 1 citation

Introduction to the Special Section on Psychedelics Research and Treatment Dominic Sisti Against a backdrop of post-pandemic malaise, diseases of despair, and a fragmented mental health care system, psychedelics have enjoyed a resurgence of interest as powerful psychotherapeutic agents and as catalysts of personal growth. The true power of these substances—some of which are considered...

DOI: 10.1353/pbm.2024.a919714 (opens in new tab) Section typography Special section

Psilocybin Therapy for Depression: A Review of Current Molecular Knowledge

Journal of the Netherlands Society of Toxicology 2024 Marcha Verheijen 1 citation

Depression, affecting over 264 million people globally, presents significant treatment challenges, often due to the limited efficacy and adverse effects of traditional antidepressants and the accessibility issues associated with psychotherapy. Recent advancements in psychedelic-assisted therapy, particularly using psilocybin, a naturally occurring compound found in “magic mushrooms”, shows...

DOI: 10.61833/jnst.2024.0002 (opens in new tab) Full text (opens in new tab) Psilocybin Depression economics Current fluid Psychotherapist +1